VIVALESSENCE H
Food supplement declared in France, decision dated 11 November 2026
VIVALESSENCE H (BOTALI) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.
- Brand
- BOTALI
- Food business operator placing the product on the market
- Laboratoire Motima
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 30 à 50 gouttes
- Directions for use
- 30 à 50 gouttes dans un verre d'eau ou de jus de fruit en cure de 14 jours,
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : Gorge
Declaration 376033, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Lavandula angustifolia subsp. pyrenaica (DC.) Guinea | Essence (sommités fleuries) | Distillation | 20 mg |
| Avena sativa L. | Graine | Extrait fluide hydroalcoolique | 10 mg |
| Cinnamomum verum J. Presl | Essence (bois, écorce) | Distillation | 6 mg |
| Satureja hortensis L. | Sommités fleuries | Distillation | 6 mg |
| Eucalyptus globulus Labill. | Essence (feuille) | Distillation | 6 mg |
Other ingredients
eau, Alcool
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé en cas d’allergie connue à l’Eucalyptus ou au 1,8-cinéole, en cas d’allergie à la cannelle ou au baume du Pérou, en cas d’ulcère de l’estomac ou de gastrite. Déconseillé en cas de conduite automobile ou d'utilisation de machines. Ne pas dépasser 14 jours de prise.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cinnamomum verum J. Presl
Read the warning, when it applies and the studies cited
Cinnamon - Cinnamomum Verum
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé.
Condition of application: All products except antioxidants.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant (Brinker 2010; BHC 2006; Blumenthal 2000).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
- BHC 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drugs—Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- VIVALESSENCE H BOTALI, declared in 2021 : different composition: 2 ingredient(s) added, 2 missing
Brand : BOTALI
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.